More here: Valneva - Déclaration d’actions et de droits de vote – NOVEMBRE 2020
More here: Valneva - Déclaration d’actions et de droits de vote – NOVEMBRE 2020
Excerpt from: Virbac : Declaration of the number of shares and voting rights 11/2020
View original post here: Novartis announces first data from REACH3 trial showing Jakavi® (ruxolitinib) significantly improved outcomes in patients with...
Original post: Galapagos increases share capital through subscription right exercises
See the rest here: Fulcrum Therapeutics Presents Updated Data on Sickle Cell Disease Program at the 62nd American Society of Hematology (ASH) Annual Meeting and...
Go here to see the original: Novartis analyses confirm benefit of Kymriah® with clinically meaningful rates of complete response seen in patients with certain advanced lymphomas
See the original post here: Intellia Therapeutics Presents New Preclinical Data Supporting Its CRISPR/Cas9-Engineered TCR-T Cell Treatment for Acute Myeloid Leukemia at the...
Recent Comments